UNSPSC 51286703: Iclaprim

This classification denotes an antibiotic with the molecular formula C19H22N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42445HUU0O, chemically known as 5-((2rs)-2-cyclopropyl-7,8-dimethoxy-2h-chromen-5-ylmethyl)pyrimidine-2,4-diamine but more generally known as iclaprim, which bears US NIH Compound Identifier 213043. European Medicines Agency schedules Iclaprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32201.

The term ICLAPRIM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 17, No. 4, 2003, List 50). The World Health Organization schedules iclaprim in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: O1C(C2CC2)C=CC2C1C(OC)C(OC)CC2CC1C(NC(NC1)N)N.

UNSPSC 51286703 Iclaprim, a Commodity code, does not reflect the scope of work actually being solicited in recent state and local activity. The code is nominally pharmaceutical in character, but the recent solicitations tagged under it span naloxone and drug deactivation systems, medical and first-aid supplies for fire rescue operations, direct-to-manufacturer prescription program design, and generic multi-source pharmaceuticals through cooperative purchasing — none of which align with iclaprim's specific pharmacological use case. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (Tampa Fire Rescue Division), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local jurisdictions including Oregon). The code shows little relevant recent activity for iclaprim itself; the tagging appears to be a data-quality issue rather than a signal of active procurement demand.

The geographic spread covers Florida, Texas, Minnesota, and Oregon based on the recent opportunities. Representative activity includes Seminole County's IFB for naloxone and safe drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually, due July 26, 2023); the City of Tampa's IFB for medical and first-aid supplies for the Fire Department Rescue Division (169 line items, $700,000 estimated contract, SLBE set-aside with 5 percent bid discount, due March 13, 2026); the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026, exploratory market intelligence with no formal award value); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (proposals due March 26, 2026, serving state and local facilities across multiple states). If iclaprim procurement activity exists at the state or local level, the available record does not surface it.